“It’s Time for More Time” With the #MoreTime campaign, the Alzheimer’s Association has gone all in on aducanumab, the controversial new Alzheimer’s drug produced…
A few months ago, we discovered some disturbingly large and firm lumps on our dog Sadie. We quickly made an appointment with the vet…
Jason Karlawish is disappointed. Angry even. Read his new book The Problem of Alzheimer’s: How Science, Culture and Politics Turned a Rare Disease Into…
Biogen’s Alzheimer’s drug aducanumab encounters another bump in the road as the FDA delays its approval decision. The Federal Drug Administration has given itself…
Even though the Alzheimer’s drug aducanumab has faced many twists and turns along its path to FDA approval, experts say that approval of Biogen’s…
The initial results from Eli Lilly and Co’s Phase 2 clinical trial for experimental Alzheimer’s drug donanemab provide much needed hope for the Alzheimer’s…
In a surprising turn of events, the Advisory Committee of experts on Biogen’s experimental Alzheimer’s drug aducanumab recommended against FDA approval of the drug…
UPDATE: 3 March 2024, 8:19 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
In yet another encouraging step toward the development of what could be the first drug approved for Alzheimer’s disease, the Federal Drug Administration today…
A survey of all drugs currently in clinical trials for Alzheimer’s disease found 121 unique therapies being tested in 136 Alzheimer’s drug trials. That…
The latest news about Biogen’s controversial Alzheimer’s drug popped into my email at 8:26 a.m. last Wednesday. Coincidentally it arrived just as I was…
Well, I won’t try that again. Last week, I found myself bent over a table, resting my head on pillows as a doctor injected…
Hours feel like days. Days feel like months. And months? Well they can feel like a decade. Particularly when you are awaiting the restart…
The response was disappointing but not particularly surprising. Earlier in the day, I had sent a quick email to check in with the staff…
Jeff Borghoff today took yet another small step toward finding a cure for Alzheimer’s disease as he became the first person in the world…